Abstract: The present invention relates to a breast prosthesis allowing controlled release of a drug and to a production method for same, and more specifically, relates to a breast prosthesis allowing controlled release of a drug by the coupling of a drug layer comprising particles carrying the drug on the breast prosthesis, and to a production method for same.

Abstract: A method of preparing a reprogramming induced pluripotent stem cell from a human-derived somatic cell using a fusion protein in which a reprogramming inducing factor and cell permeable peptide (CPP) are fused, and a fusion protein in which a reprogramming inducing factor and a cell permeable peptide are fused are disclosed. According to the present invention, the induced pluripotent stem cell having high efficiency and high stability can be prepared by maximizing the effect of the reprogramming inducing transcription factor beyond the existing viral peptide transporter, in inducing the reprogramming of the somatic cell.

Abstract: The present invention provides a method and apparatus for performing device-to-device communication in a wireless communication system. The method includes generating identification information of a D2D user equipment that supports the D2D communication as identification information for D2D discovery using a hash function, the identification information for discovery includes information of a first length for indicating a division region of the beacon signals and information of a second length included in the beacon. The information of a first length and the information of a second length are smaller than identification information of the D2D user equipment. Accordingly, by performing discovery for the D2D user equipment through the identification information having shorter length than prior art, and performing discovery in a range where the discovery is available through the region in which the beacon signals are allocated, advantages of performing the D2D discovery effectively are provided.

Abstract: The present invention relates to A method for promoting the differentiation of myoblasts comprising treating myoblasts with butylpyridinium, a derivative thereof, or a pharmaceutically acceptable salt thereof; a method for strengthening muscles comprising administering butylpyridinium, a derivative thereof, or a pharmaceutically acceptable salt thereof to a subject in need thereof; a feed or feed additive for strengthening muscles comprising butylpyridinium, a derivative thereof, or a pharmaceutically acceptable salt thereof; a method for treating a disease associated with muscle weakness comprising administering butylpyridinium, a derivative thereof, or a pharmaceutically acceptable salt thereof to a subject in need thereof.

Abstract: Disclosed is a technique capable of effectively estimating a three-dimensional location of a target node through a geometric access by using location information of three anchor nodes. The height of a tetrahedron is calculated. Projected estimated distances, obtained by projecting the estimated distances on a plane H formed by the three anchor nodes, and coordinate values of the three anchor nodes converted on a second coordinate system of the plane H are obtained, and then trilateration is performed using the projected estimated distances and the converted coordinate values so as to calculate an estimated location, projected on the plane H, of the target node. A coordinate value of the calculated estimated location is converted into a coordinate value on a first coordinate system and then the height of the tetrahedron is reflected thereto so as to obtain a coordinate value of the three-dimensional estimated location of the target node.

Abstract: The present invention relates to a Gremlin-1 antibody that inhibits Gremlin-1 in a manner independent of bone morphogenetic protein (BMP) or vascular endothelial growth factor receptor-2 (VEGFR-2), thus providing the effect of treating cancer. The antibody of the present invention inhibits cell migration, cell invasion and cell proliferation which are dependent on Gremlin-1, and therefore, can be effectively used in treating cancer or immune disease.

Abstract: A super conductor is formed by a process including a first step of forming liquid-phase rare earth-copper-barium oxide by heat treating a superconductor precursor including a rare earth element, barium, and copper, a second step of forming a first superconductor of the rare earth-copper-barium oxide that is epitaxially grown from the liquid-phase rare earth-copper-barium oxide, and a third step of forming a second superconductor of the rare earth-copper-barium oxide by heat treating the first superconductor, wherein the heat treatment of the third step is performed in an atmosphere in which the rare earth-copper-barium oxide has no liquid phase.

Abstract: Apparatuses, systems, and methods for generating concentration gradients of soluble molecules are disclosed herein. Devices and methods for generating in vitro blood vessels are also disclosed.

Abstract: Disclosed herein are a positive electrode active material including at least one selected from among compounds represented by Formula 1 below and a lithium secondary battery including the same that is capable of improving lifetime characteristics and rate characteristics while exhibiting excellent safety: Li[LixMyM?(1-x-y)]O2-zAz (1), where M is at least one element selected from a group consisting of Ru, Mo, Nb, Te, Re, Ir, Pt, Cr, S, W, Os, and Po, M? is at least one element selected from a group consisting of Ni, Ti, Co, Al, Mn, Fe, Mg, B, Cr, Zr, Zn, and second row transition metals, A is a negative monovalent or divalent anion, and 0<x<0.3, 0.2?y?0.5, 0?z<0.5, and 0.2<x+y<0.8.

Abstract: Example methods of fabricating a circuit board are disclosed. An example method includes providing a substrate, forming at least one or more channels having linear nanostructures on the substrate, and forming a first electrode and a second electrode on the substrate, where the at least one or more channels electrically couple the first electrode to the second electrode.

Abstract: Provided are a method for forming a pattern, and a catalyst and an electronic element using the method. The method for forming a pattern comprises the steps of: preparing, on a surface, a substrate sequentially including a photoconductive material layer and an oxide layer; making an area, on which a pattern is to be formed, on the oxide layer of the substrate, come into contact with an electrolyte; connecting the substrate and the electrolyte to a first electrode and a second electrode connected to a power source, respectively; and selectively irradiating light from a light source to the electrolyte and applying a voltage to the first electrode or the second electrode, thereby directly forming the pattern on the oxide layer of the substrate.

Abstract: Disclosed are a biosignal measurement device and a capacitively-coupled active electrode. The capacitively-coupled active electrode includes an electrode face configured to form capacitive coupling with a subject in a non-contact manner to detect a biosignal, and a pre-amplifier disposed on a rear side of the electrode face and embedded in a porous insulator.

Abstract: The present invention relates to a pharmaceutical composition containing a G protein coupled receptor 119 (GPR119) ligand as an active ingredient for preventing or treating non-alcoholic fatty liver disease. More particularly, it was confirmed that the GPR119 ligand, which has been developed as only an anti-diabetic drug, exhibits superior effects on the treatment of non-alcoholic fatty liver and the signal pathways in hepatocytes therefor differ from the signal pathways in the small intestine and the pancreas exhibiting anti-diabetic effects, whereby the GPR119 ligand can be useful to treat non-alcoholic fatty liver.

Abstract: The present invention relates to novel 2,4-pyrimidine derivatives and a use thereof, and more particularly, to pyrimidine derivatives which are effective for systemic lupus erythematosus, a composition for preventing and treating systemic lupus erythematosus comprising the same as an active ingredient and a method for screening the same. The present inventors found novel materials inhibiting surface translocation of gp96 by mimicking a function of AIMP1 which is a molecular anchor for an intracellular residence of gp96, and identified in vitro and in vivo activity of the materials for preventing and treating SLE by alleviating SLE plasma in autoimmune diseases. Therefore, the present invention provides a novel method for screening a therapeutic agent for SLE, and preventing or treating SLE using the mechanism.

Abstract: A method for transmitting a spread spectrum radar signal stores a plurality of spread sequences. Further, an elevation of a vehicle is measured by the method. Based on the measured elevation of the vehicle, the method selects at least one spread sequence of the plurality of spread sequences, and transmits a spread spectrum radar signal based on the selected at least one spread sequence. Additionally, the method may measure a travel direction of the vehicle, and then select at least one spread sequence based on the measured elevation of the vehicle and the measured travel direction of the vehicle.

Abstract: A method and apparatus for transmitting channel information used by a station form among TV white space channels, and a method and apparatus for performing channel switching are disclosed.

Abstract: There is provided a stretchable substrate including: a substrate having first Young's modulus and stretchability; and plurality of strain control patterns having second Young's modulus and arranged on the substrate, in which strain due to an external force depends on arrangement of the plurality of strain control patterns.

Abstract: Provided is a color encoding method including providing a composition including a liquid medium and magnetic nanoparticles dispersed in the liquid medium; applying a magnetic field to the composition to align the magnetic nanoparticles; and applying a patterned energy source to the composition to solidify the composition, wherein more than one region of the composition are sequentially solidified with varying magnetic field strength to fix a plurality of color codes.

Abstract: This disclosure relates to a method for preparing organic microbubble complex particles including sonicating an aqueous solution including a graphene compound and an amphiphilic material in the presence of a gas, a method for preparing organic microbubble complex particles including injecting an aqueous solution including a graphene compound and an amphiphilic material into a microchannel, and an organic microbubble complex particle including a core part including at least one gas selected from the group consisting of an inert gas and carbon dioxide, and a shell layer including a graphene compound and an amphiphilic material, and an ultrasound contrast agent including the organic microbubble complex particles.

Abstract: A confocal fluorescence microscope of the present invention consists of: a light source unit broadly comprising one or more short wavelength laser beams; a lens unit which converts parallel light, emitted from a light source, into linear light having an appropriate size; a multi-color mirror which reflects the light source and enables fluorescence to transmit so as to separate the light source and the fluorescence; a scan mirror which radiates the light source over a wide area and scatters the fluorescence over a large-area camera; a microscope unit which radiates the incident light source to a target object, collects the fluorescence emitted from the target, and outputs the collected fluorescence; and a detecting unit which removes the background of the outputted fluorescent signal and observes the outputted fluorescent signal.